Payne Fletcher 4
4 · CATALYST BIOSCIENCES, INC. · Filed Feb 13, 2019
Insider Transaction Report
Form 4
Payne Fletcher
Chief Financial Officer
Transactions
- Award
Common Stock
2019-02-11$7.04/sh+1,002$7,054→ 3,731 total
Holdings
- 501(indirect: By Trust)
Common Stock
- 666(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 11, 2019.
- [F2]A Section 16 exempt transaction was completed.